Key Topics. Richard A. Tucker. Issues Initiating a DEA Investigation Richard A. Tucker. POFPS 40th Annual CME Symposium August 7-9,
|
|
- Melvin Chad Robertson
- 7 years ago
- Views:
Transcription
1 What to Expect During a Visit from the Drug Enforcement Administration Consultant Drug Education Consulting Group 1 Drug Education Consulting Group Educate corporate/private groups on drug trafficking and its impact on society 25 years as Special Agent with the DEA (Retired in 2008) Served Assignments in Atlanta, Denver, El Paso, Los Angeles and Thailand Investigated global drug trafficking organizations Served in Washington, D.C. as Chief of DEA s International Intelligence Program 10 Years as a Police Officer in Cobb County, Georgia Served on multi-agency narcotics unit investigating regional and local narcotics issues, including diversion of prescription drugs Conducted numerous undercover assignments; taught undercover techniques at police academies. 2 Key Topics Common reasons for DEA Investigations Outcomes if issues are discovered in an investigation. Does an interview mean I am in trouble? Where can I expect the investigation go? What is prescribing for a legitimate medical purpose versus improper behavior. 3 August 7-9,
2 Who or What is the Drug Enforcement Administration? The Drug Enforcement Administration was created by President Richard Nixon through an Executive Order in July 1973 in order to establish a single unified command to combat "an all-out global war on the drug menace." At its outset, DEA had 1,470 Special Agents and a budget of less than $75 million. Today, the DEA has nearly 5,000 Special Agents, 525 Diversion Investigators,700 Intelligence Research Specialists and a budget of $2.02 billion. 4 Diversion of Controlled Pharmaceuticals Many of the narcotics, depressants, and stimulants manufactured for legitimate medical use are subject to abuse and have, therefore, been brought under legal control. Under federal law, all health professionals licensed to dispense, administer, or prescribe them must register with the DEA. Registrants must comply with regulatory requirements relating to drug security and record keeping. Diversion investigations involve, but are not limited to, physicians who sell prescriptions to drug dealers or abusers; pharmacists who falsify records and subsequently sell the drugs; employees who steal from inventory and falsify orders to cover illicit sales; prescription forgers; and individuals who commit armed robbery of pharmacies and drug distributors. 5 Closed System of Distribution Investigations Established Schedules Record Keeping Requirements Registration Security Requirements ARCOS Established Quotas 6 August 7-9,
3 DEA Mission To prevent, detect, and investigate the diversion of controlled substances from legitimate sources while Ensuring an adequate and uninterrupted supply for legitimate medical and scientific purposes. 7 DEA Authority to Investigate Diversion The DEA derives its authority to pursue its Diversion Control program from federal law. Specifically the Controlled Substances Act (CSA), 21 U.S.C , and the corresponding regulations found at 21 CFR Part , give DEA the authority and responsibility to monitor and regulate pharmaceutical controlled substances. These same laws and regulations also set forth the requirements of physicians and other health care providers who have authority to prescribe, dispense and/or administer controlled substances. 8 Expectations of a DEA Visit to a Practice Drug Enforcement Administration (DEA), Diversion Investigators can make periodic unannounced inspection/audits to registrants. Always be prepared, a DEA visit could occur late in the afternoon or near holiday weekends. The purpose of inspection/audits is to ensure that the registrant is complying with the Controlled Substance Act and to bring them back into compliance if they are not. Investigators could also be looking for suspected criminal activity. Registrants must be aware that the DEA is a law enforcement agency. Upon arrival a DEA Diversion Investigator will present to the registrant their credentials and photo identification. Afterward, the DEA Diversion Investigators will request informed consent by having the registrant or authorized personnel sign a Notice of Inspection (DEA Form 82) or present a search warrant for items that are to be reviewed. 9 August 7-9,
4 Methods of Diversion Illegal sales Internet Employee theft Prescription rings Doctor shopping Inappropriate prescribing Fraudulent prescriptions Pharmacy theft Foreign diversion and smuggling into the U.S. 10 DEA s Role in Prescribing Controlled Substances DEA's role under the Controlled Substances Act (CSA) is to ensure that controlled substances are prescribed, administered, and dispensed only for legitimate medical purposes by DEA-registered practitioners acting in the usual course of professional practice and otherwise in accordance with the CSA and DEA regulations. Each State also has its own laws (administered by State agencies) requiring that a prescription for a controlled substance be issued only for a legitimate medical purpose by State-licensed practitioners acting in the usual course of professional practice DEA Published Position Federal Register, Vol. 71, No. 172, Prevent abuse and diversion without adversely impacting the legitimate need of patients to have full access to pain relief prescribed by their physician The entirety of the circumstance is considered The cases in which physicians have been found to have prescribed improperly typically involve blatant criminal conduct The percentage of physicians who prescribe improperly (or are investigated for doing so) is extremely small 12 August 7-9,
5 A Valid Prescription A prescription is an order for medication which is dispensed to or for an ultimate user. A prescription is not an order for medication which is dispensed for immediate administration to the ultimate user (for example, an order to dispense a drug to an inpatient for immediate administration in a hospital is not a prescription). A prescription for a controlled substance must be dated and signed on the date when issued. The prescription must include the patient s full name and address, and the practitioner s full name, address, and DEA registration number. The prescription must also include: drug name strength dosage form quantity prescribed directions for use number of refills (if any) authorized A prescription for a controlled substance must be written in ink or indelible pencil or typewritten and must be manually signed by the practitioner on the date when issued. An individual (secretary or nurse) may be designated by the practitioner to prepare prescriptions for the practitioner s signature. The practitioner is responsible for ensuring that the prescription conforms to all requirements of the law and regulations, both federal and state Legitimate Medical Purpose Usual Course of Professional Practice This requirement has been construed by the courts to mean that the Rx must be issued in accordance with a standard of medical practice generally recognized and accepted in the United States. United States v. Moore 423 U.S. 122 (1975) 14 Inspections Versus Investigations Is There a Difference? During a typical audit/inspection, DEA Investigators will verify security practices and compare the records of controlled substances prescribed or dispensed. According to the Code of Federal Regulations, there is no acceptable discrepancy range for DEA purposes. The inspection could also be searching for elements of criminal activity. Keep in mind that just because investigators want to interview you, doesn t always mean you are the target of their inquiry, but it also doesn t mean you aren t. Preliminary background and data base checks have already been done and there may be specific questions to ask you. There has more than likely been a complaint that has led to the visit. The more specific the complaint the more thorough the actions. 15 August 7-9,
6 Does Consent Have to Given During an Inspection If consent is not given or withdrawn, Diversion Investigators and/or Special Agents can make application for an Administrative Warrant signed by any judge of the United States or of a State court of record, or any United States magistrate judge. The warrant shall identify the items or types of property to be seized, if any and: Note who is authorized to serve the warrant What may be seized pursuant to the warrant What authority the warrant return must be made 16 Criminal Investigations 17 Factors Leading to an Investigation DEA document contained in the Federal Register states: This does not mean that the existence of any of the foregoing factors will automatically lead to the conclusion that the physician acted improperly. Rather, each case must be evaluated based on its own merits in view of the totality of circumstances particular to the physician and patient. Rather than focusing on any particular factor, it is critical to bear in mind that (i) the entirety of circumstances must be considered, (ii) the cases in which physicians have been found to have prescribed controlled substances improperly typically involve facts that demonstrate blatant criminal conduct, and (iii) the percentage of physicians who prescribe controlled substances improperly (or are investigated for doing so) is extremely small. FR Doc. E F.2d 1032 UNITED STATES of America, Plaintiff- Appellee,v. Isadore I.ROSEN, Defendant-Appellant 18 August 7-9,
7 Legitimate Medical Purpose (What the Courts say) (1)An inordinately large quantity of controlled substances was prescribed. United States v. Behrman, 258 U.S. 280, 42 S.Ct. 303, 66 L.Ed. 619 (1922); United States v. Warren, 453 F.2d 738 (2nd Cir.), Cert. denied, 406 U.S. 944, 92 S.Ct. 2040, 32 L.Ed.2d 331 (1972); United States v. Brandenburg, 155 F.2d 110 (3rd Cir. 1946). (2) Large numbers of prescriptions were issued. United States v. Abdallah, 149 F.2d 219 (2nd Cir.), Cert. denied, 326 U.S. 724, 66 S.Ct. 29, 90 L.Ed. 429 (1945). (3) No physical examination was given. United States v. Warren, supra; White v. United States, 399 F.2d 813 (8th Cir. 1968); Brown v. United States, 250 F.2d 745 (5th Cir.), Cert. denied, 356 U.S. 938, 78 S.Ct. 779, 2 L.Ed.2d 812 (1958); United States v. Brandenburg, supra. (4) The physician warned the patient to fill prescriptions at different drug stores. United States v. Abdallah, supra F.2d 1032 UNITED STATES of America, Plaintiff- Appellee,v. Isadore I.ROSEN, Defendant-Appellant 19 Legitimate Medical Purpose (What the Courts say) (5) The physician issued prescriptions to a patient known to be delivering the drugs to others. United States v. Warren, supra. (6) The physician prescribed controlled drugs at intervals inconsistent with legitimate medical treatment. United States v. Brandenburg, supra. (7) The physician involved used street slang rather than medical terminology for the drugs prescribed. United States v. Larson, 507 F.2d 385 (9th Cir. 1974). (8) There was no logical relationship between the drugs prescribed and treatment of the condition allegedly existing. See United States v. Behrman, supra; Webb v. United States, 249 U.S. 96, 39 S.Ct. 217, 63 L.Ed. 497 (1919); United States v. Warren, supra; White v. United States, supra; United States v. Brandenburg, supra. (9) The physician wrote more than one prescription on occasions in order to spread them out. United States v. Bartee, 479 F.2d 484 (10th Cir. 1973); United States v. Larson, supra F.2d 1032 UNITED STATES of America, Plaintiff- Appellee,v. Isadore I.ROSEN, Defendant-Appellant 20 What About Patient Charts? Your patient files and charts should be complete and accurate, clearly legible, fully articulate and document each patient medical history, your thorough physical examination conducted, medical diagnosis and justification for writing any controlled substance prescription being issued to a patient for a legitimate medical purpose as well as any authorization for refills. The files and charts should be absent of red flags that will require further investigation by DEA. When appropriate your files and charts should include results of blood work, electronic imaging such as: x-rays, scans and/or MRI testing, additional physician consults and opinions and your follow-up with the patient. Some doctors have included the results of random urinalysis drug screening for patients who regularly receive controlled substance prescriptions to assure they are legitimately using the medication and not diverting the drugs August 7-9,
8 Purpose for Issuing a Prescription To be valid, a prescription for a controlled substance must be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. The practitioner is responsible for the proper prescribing and dispensing of controlled substances. In addition, a corresponding responsibility rests with the pharmacist who fills the prescription. An order purporting to be a prescription issued not in the usual course of professional treatment or in legitimate and authorized research is not a valid prescription within the meaning and intent of the Controlled Substances Act and the person knowingly filling such a purported prescription, as well as the person issuing it, shall be subject to the penalties provided for violations of the provisions of law relating to controlled substances. A prescription may not be issued in order for an individual practitioner to obtain controlled substances for supplying the individual practitioner for the purpose of general dispensing to patients Tactical Diversion Squads The Tactical Diversion Squads combine DEA resources with those of federal, state and local law enforcement agencies in an innovative effort to investigate, disrupt and dismantle those suspected of violating the Controlled Substances Act or other appropriate federal, state or local statutes pertaining to the diversion of licit pharmaceutical controlled substances or listed chemicals. The Tactical Diversion Squads : Allow for the unification of separate and sometimes disparate federal, state, and local information, authorities, and enforcement programs Help coordinate with various judicial districts to maximize the effectiveness of multiple investigations and prosecutions of those involved in the diversion of controlled substances or listed chemicals Support traditional Diversion Groups when law enforcement authority is required (i.e., making arrests, purchase of evidence, payment of information, conducting surveillance, executing a search warrant) 23 Applying criminal sanctions to doctors Registered physicians can be prosecuted under [21 U.S.C.] 841 when their activities fall outside the usual course of professional practice. United States v. Moore 423 U.S. 122 (1975) 24 August 7-9,
9 Prescription Requirements 21 CFR A controlled substance prescription may only be issued by a duly licensed and (DEA) registered practitioner. 21 CFR A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice. (Pharmacies have a responsibility to ensure prescriptions adhere to this directive.) 25 Legitimate Medical Purpose Usual Course of Professional Practice (One More Time) This requirement has been construed by the courts to mean that the Rx must be issued in accordance with a standard of medical practice generally recognized and accepted in the United States. United States v. Moore 423 U.S. 122 (1975) 26 Personnel Precautions The registrant shall not employ, as an agent or employee who has access to controlled substances, any person who has been convicted of a felony offense relating to controlled substances or who, at any time, had an application for registration with the DEA denied, had a DEA registration revoked or has surrendered a DEA registration for cause. For purposes of this subsection, the term "for cause" means a surrender in lieu of, or as a consequence of, any federal or state administrative, civil or criminal action resulting from an investigation of the individual's handling of controlled substances August 7-9,
10 Employee Screening DEA recommends that inquiries concerning employees' criminal records be made as follows: Local inquiries. Inquiries should be made by name, date and place of birth, and other identifying information, to local courts and law enforcement agencies for records of pending charges and convictions. Local practice may require such inquiries to be made in person, rather than by mail, and a copy of an authorization from the employee may be required by certain law enforcement agencies. Inquiries supplying identifying information should also be furnished to DEA Field Division Offices along with written consent from the concerned individual for a check of DEA files for records of convictions. The regional check will result in a national check being made by the Field Division Office Advice for a Practice During an Inspection Since inspections may occur at any time during typical business hours, the registrant must have an action plan that is reviewed by all authorized personnel on how to immediately retrieve the necessary documentation required for a DEA inspection. Review the DEA Diversion Inspectors credentials and obtain their contact information. Inquire the reason for the inspection. Have all documentation readily available. Take notes of all recommendations and observations made by the DEA Diversion Investigators. Obtain a location in the office to allow the investigators to review records and policies. Ask any questions you may have regarding their findings so corrective actions can be implemented. Be polite and cordial. Do not argue or debate with the investigators. 29 No Finding Possible Outcomes of DEA Investigation Letter of Admonishment Criminal Charges Memo of Agreement Could limit prescribing Could include voluntary surrender of DEA # 30 August 7-9,
11 Valuable Law Enforcement Resources DEA Office of Diversion Office of National Drug Control Policy National Association of Drug Diversion Investigators - NADDI 31 Protecting Prescribing Practices This program is NOT intended to discourage the prescribing or dispensing of appropriate medication for legitimate medical purposes. Physicians and other authorized prescribers should not allow those who divert or misuse prescription drugs to influence the legitimate prescribing and dispensing of controlled substances. The material presented in this presentation is made with the understanding and agreement that Richard Tucker d/b/a Drug Education Consulting Group is not engaged in rendering legal or other professional services by presenting said material. The material is presented as educational material only. The services of a competent professional should be sought if legal or other specific expert assistance is required. 32 DISCLAIMER The material presented in this presentation is made with the understanding and agreement that Richard Tucker d/b/a Drug Education Consulting Group is not engaged in rendering legal or other professional services by presenting said material. The material is presented as educational material only. The services of a competent professional should be sought if legal or other specific expert assistance is required. 33 August 7-9,
12 The Drug Education Consulting Group Telephone: August 7-9,
DEA Washington Division Diversion Control Program
SOUTHWEST VIRGINIA PRESCRIPTION DRUG ABUSE SUMMIT DEA Washington Division Diversion Control Program Mary Johnson-Rochee Diversion Program Manager November 14, 2012 Topics: DEA s Diversion Mission How DEA
More informationDrug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
More informationUNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION CRIMINAL COMPLAINT
AO 91 (Rev. 11/11) Criminal Complaint AUSA Sarah Streicker (312) 353-1415 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION UNITED STATES OF AMERICA v. CASE NUMBER: UNDER SEAL
More informationSUBCHAPTER IV. OFFENSES AND PENALTIES
DISTRICT OF COLUMBIA OFFICIAL CODE TITLE 48. FOOD AND DRUGS SUBTITLE III. ILLEGAL DRUGS CHAPTER 9. CONTROLLED SUBSTANCES UNIT A. CONTROLLED SUBSTANCES ACT SUBCHAPTER IV. OFFENSES AND PENALTIES 48-904.01.
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationControlled Substance Policy for Research
Controlled Substance Policy for Research The University of North Carolina at Greensboro Approved 7/1/2013 I. Purpose University researchers may, in the course of lawful research, teaching or testing, find
More informationPharmacy Law Overview. From Civil Liability to Criminal Prosecution
Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy
More informationAchieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
More informationIN THE THIRD DISTRICT COURT IN AND FOR SALT LAKE COUNTY SALT LAKE DEPARTMENT, STATE OF UTAH : : : : : : : : :
SEAN D. REYES, Attorney General (7969) LANA TAYLOR, Assistant Attorney General (7642) WAYNE D. JONES, Assistant Attorney General (7235) Attorneys for the State of Utah 5272 South College Dive, Suite 200
More informationA Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law
Knowledge replaces fear. A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Note: Though this article concerns requests made by federal Drug Enforcement Administration investigators
More informationWhat Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
More informationGreater Altoona Career & Technology Center ADULT EDUCATION DRUG & ALCOHOL POLICY
The Greater Altoona Career & Technology Center recognizes that the abuse of controlled substances is a serious problem with legal, physical and social implications for the whole school community. As an
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationNEW/RENEWAL APPLICATION FOR PAIN MANAGEMENT CLINIC REGISTRATION
Department of Regulatory and Economic Resources Business Affairs Division Office of Consumer Protection 601 NW 1st Court, 18th Floor Miami, Florida 33136 Tel: 786-469-2300 Fax: 786-469-2311 email: license@miamidade.gov
More information"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee
DEA Congressional Testimony December 4, 2007 Statement of Joseph T. Rannazzisi Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration "Electronic Prescribing of Controlled
More informationPursuant to the authority vested in the Commissioner of Health by Article 33 of the
Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health
More informationI-2008-002. Review of the Drug Enforcement Administration s Use of the Diversion Control Fee Account. February 2008
Review of the Drug Enforcement Administration s Use of the Diversion Control Fee Account February 2008 I-2008-002 EXECUTIVE DIGEST INTRODUCTION The (OIG) initiated this review in response to congressional
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationControlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More informationDEA REGISTRATION FEES FACT SHEET
DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants
More informationWASHINGTON LAWS, 1987
ensure compliance with this chapter and the treatment standard authorized by this chapter. A methadone treatment center shall not have a caseload in excess of three hundred fifty persons. The caseload
More informationNOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
More informationDeveloped by the Centers for Medicare & Medicaid Services
Developed by the Centers for Medicare & Medicaid Services Every year millions of dollars are improperly spent because of fraud, waste, and abuse. It affects everyone. Including YOU. This training will
More information1 st Tier & Downstream Training Focus
Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste
More information12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
More informationLos Angeles County Department of Mental Health Credentialing Application for Prescribing Practitioners Delivering Services to DCFS Children
Los Angeles County Department of Mental Health Credentialing Application for Prescribing Practitioners Delivering Services to DCFS Children This application is exclusively for prescribing practitioners
More informationMedicare Compliance and Fraud, Waste, and Abuse Training
Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques
More informationNarcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
More informationDIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292
DIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292 COMMUNITY PHARMACY PERMIT APPLICATION AND INFORMATION August 2012
More informationMEMORANDUM. Employees. Human Resources AGENCY DRUG-FREE WORKPLACE POLICY
MEMORANDUM TO: FROM: RE: Employees Human Resources AGENCY DRUG-FREE WORKPLACE POLICY Attached is a copy of the Mississippi Department of Health s established Drug-Free Workplace Policy. This policy reflects
More informationMedicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
More informationSubject: Health; prescription drugs; Vermont Prescription Monitoring 5 System
0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill
More informationMODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING
MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING 2 0 1 4 Introduction The Medicare and Medicaid programs are governed by statutes, regulations, and policies PacificSource must have an effective
More information13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of
More informationDiscrepancies are claims that appear to have unusual or potentially abusive, wasteful or fraudulent elements (e.g., quantity, days supply).
Purpose: Provide guidelines for pharmacies for audits and appeals of pharmacy audit findings resulting from MedImpact auditor data review and claims selection for identification of potential fraud, waste
More informationDefinitions: The Certification of Exemption memorandum must be signed by the principal investigator s dean or department chair.
University of Pittsburgh Guidelines for the Ordering and Use of Prescription Drugs and Devices and Controlled Substances for Non- Clinical Laboratory Research Definitions: 1. Authorized Agent(s) of the
More informationKentucky Board of Medical Licensure. Consumer s Guide to the KBML. To Whom It May Concern. Information on Filing a Grievance
Kentucky Board of Medical Licensure Hurstbourne Office Park 310 Whittington Parkway, Suite 1B Louisville, Kentucky 40222 Telephone: 502/429-7150 Fax: 502/429-7158 Website: www.kbml.ky.gov TO: FROM: RE:
More informationMEDICARE DRUG INTEGRITY CONTRACTORS IDENTIFICATION
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL MEDICARE DRUG INTEGRITY CONTRACTORS IDENTIFICATION OF POTENTIAL PART D FRAUD AND ABUSE Daniel R. Levinson Inspector General October 2009
More informationProvider Beware The Collateral Consequences of a Guilty Plea
Attorney General Medical Board Pharmacy Board Medicaid Health Department CMS DEA FBI Medicare OIG security You re A Target. We Can Help. Health care providers face more scrutiny than ever before. Government
More informationCHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:
CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.
More informationSenate Bill No. 38 Committee on Transportation and Homeland Security
Senate Bill No. 38 Committee on Transportation and Homeland Security CHAPTER... AN ACT relating to criminal records; creating the Records and Technology Division of the Department of Public Safety; enumerating
More information(2) Minutes shall be maintained for advisory board meetings.
ACTION: Refiled DATE: 08/18/2015 9:45 AM 5122-29-12 Driver intervention program. (A) A driver intervention program is a program of screening, education, and referral for individuals who are arrested or
More informationCHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No.
CHAPTER 2010-211 Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. 2722 An act relating to controlled substances; amending s. 456.037,
More informationARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:
ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:
More informationREFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1381 Prescription Drug Monitoring Program SPONSOR(S): Davis TIED BILLS: IDEN./SIM. BILLS: REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF
More informationThe following procedures are established in implementation of Policy 5530, Substance Abuse.
R 5530 SUBSTANCE ABUSE R 5530/page 1 of 16 M The following procedures are established in implementation of Policy 5530,. A. Definitions 1. Evaluation means procedures used by a certified or licensed professional
More informationThe following procedures are established in implementation of Policy No. 5530, Substance Abuse.
R5530.DR Page 1 of 11 The following procedures are established in implementation of Policy No. 5530,. A. Definitions 1. Evaluation means those procedures used by a certified or licensed professional to
More information803 CMR: DEPARTMENT OF CRIMINAL JUSTICE INFORMATION SERVICES 803 CMR 7.00: CRIMINAL JUSTICE INFORMATION SYSTEM (CJIS)
803 CMR 7.00: CRIMINAL JUSTICE INFORMATION SYSTEM (CJIS) Section 7.01: Purpose and Scope 7.02: Definitions 7.03: Criminal Justice Agency (CJA) Access to Criminal Justice Information System (CJIS) 7.04:
More informationPLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.
PLEASE READ The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.us/ New Jersey Statutes Annotated (N.J.S.A.), published by
More informationKentucky Board of Medical Licensure 310 Whittington Parkway, Suite 1B Louisville, KY 40222 (502) 429-7150
Kentucky Board of Medical Licensure 310 Whittington Parkway, Suite 1B Louisville, KY 40222 (502) 429-7150 M E M O R A N D U M TO: FROM: RE: Applicants for Surgical Assistant Certification Dawn Beahl, Surgical
More informationNOTICES OF PROPOSED RULEMAKING
NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening
More informationAdopted Rule - 11/19/14 1
Adopted Rule - 11/19/14 1 CHAPTER Ph 800 PHARMACY TECHNICIANS Statutory Authority: RSA 318:5-a, X, XI Adopt Ph 801 & Ph 802, previously effective 7-25-01 (Doc. # 7535) and expired on 7-25-09, to read as
More informationDrug-Free Workplace. Policy Statement. Reason for the Policy. Policy V. 7.2.1
Policy V. 7.2.1 Responsible Official: Vice President for Human Resources, Diversity, and Multicultural Affairs Effective Date: October 26, 2009 Drug-Free Workplace Policy Statement The University of Vermont
More informationFraud, Waste & Abuse. Training Course for UHCG Employees
Fraud, Waste & Abuse Training Course for UHCG Employees Overview The Centers for Medicare & Medicaid Services (CMS) require Medicare Advantage Organizations and Part D Plan Sponsors to provide annual fraud,
More informationSec. 90-27. Certificates of use.
Sec. 90-27. Certificates of use. (1) It is hereby deemed unlawful for any person to open or operate any business and/or occupy any structure within the town limits for the privilege of engaging in any
More informationSAMPLE DRUG AND ALCOHOL POLICY
SAMPLE DRUG AND ALCOHOL POLICY (MISSISSIPPI) DRUG AND ALCOHOL POLICY DISCLAIMER WARNING!!! The attached Drug and Alcohol Policy is being furnished to you as a courtesy. Stonetrust Management Services highly
More informationR 5530 SUBSTANCE ABUSE (M) [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204]
R 5530/Page 1 of 17 M R 5530 [See POLICY ALERT Nos. 125, 133, 144, 145, 157, 173, 179 and 204] The following procedures are established in implementation of Policy 5530, Substance Abuse. A. Definitions
More informationDo You Know Where the Drugs Are Going?
Do You Know Where the Drugs Are Going? Presentation Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at least four
More informationRobbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12
R Robbinsville Board of Education REGULATION Section: s Regulation 5530: Substance Abuse (M) Edited: September 2014 Page 1 of 12 R 5530 SUBSTANCE ABUSE (M) The following procedures are established in implementation
More informationSample audit on Pain Management Clinic Certification and Regulation Requirements at Texas Medical Board
John Keel, CPA State Auditor An Audit Report on Pain Management Clinic Registration at the Texas Medical Board Report No. 13-037 An Audit Report on Pain Management Clinic Registration at the Texas Medical
More informationPolicies & Procedures
2.2 Drug Free Work Place Adopted 1.24.2003 Revised 3.28.2004; 5.26.2006; 3.2.2011 Reference: WAC 388.805.200(3) POLICY In accordance with "The Drug Free Workplace Act of 1988, The Healing Lodge prohibits
More informationTouchstone Health Training Guide: Fraud, Waste and Abuse Prevention
Touchstone Health Training Guide: Fraud, Waste and Abuse Prevention About the Training Guide Touchstone is providing this Fraud, Waste and Abuse Prevention Training Guide as a resource for meeting Centers
More informationPharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary
Pharmacists Responsibilities when Dispensing Controlled Substance Prescriptions Gay Dodson, R.Ph. Executive Director/Secretary Houston DEA Pharmacy Diversion Awareness Conference September 8 & 9, 2012
More informationDonald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules
D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of
More informationVermont Board of Nursing INSTRUCTION TO APPLICANTS
Vermont Secretary of State 89 Main St., 3 rd Floor Montpelier VT 05620-3402 Nursing Foreign_nurse@sec.state.vt.us www.vtprofessionals.org INSTRUCTION TO APPLICANTS The following applies to applications
More informationState of Utah Department of Commerce Division of Occupational and Professional Licensing
State of Utah Department of Commerce Division of Occupational and Professional Licensing Official Use Only Number: Date Approved/Denied: Approved/Denied By: Retired Volunteer Health Care Practitioner APPLICANT
More informationSixty-third Legislative Assembly of North Dakota In Regular Session Commencing Tuesday, January 8, 2013
Sixty-third Legislative Assembly of North Dakota In Regular Session Commencing Tuesday, January 8, 2013 HOUSE BILL NO. 1091 (Human Services Committee) (At the request of the State Board of Nursing) AN
More informationFINGERPRINT BACKGROUND CHECK
APPLICATION FOR LICENSURE PHARMACY TECHNICIAN (Non-Renewable: Expires the second June 30 from the date of issuance) OR CERTIFIED OREGON PHARMACY TECHNICIAN (Renewable: Expires September 30 th Annually)
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is
More informationMIDWIFERY JOINT COMMITTEE STATE OF NORTH CAROLINA
MIDWIFERY JOINT COMMITTEE STATE OF NORTH CAROLINA APPLICATION FOR APPROVAL AS A CERTIFIED NURSE-MIDWIFE GENERAL INFORMATION 1. BEFORE COMPLETING APPLICATION, photocopy blank forms for future use. 2. Initial
More informationState Laws Legalizing Marijuana Do Not Make Marijuana Legal Under
State Laws Legalizing Marijuana Do Not Make Marijuana Legal Under Federal Law David G. Evans, Esq. Over the last several years, a few states have passed legislation or have fostered ballot initiatives
More informationHOUSE BILL No. 2577 page 2
HOUSE BILL No. 2577 AN ACT enacting the addictions counselor licensure act; amending K.S.A. 74-7501 and K.S.A. 2009 Supp. 74-7507 and repealing the existing section; also repealing K.S.A. 65-6601, 65-6602,
More informationTitle IV Drug Violations
Title IV Drug Violations Under the Higher Education Act,( Title IV Section 485(k) students become ineligible for Federal student aid programs upon a conviction under state or federal statutes during any
More informationPrescribing Standards for Nurse Practitioners (NPs)
Prescribing Standards for Nurse Practitioners (NPs) July 2014 Approved by the College and Association of Registered Nurses of Alberta Provincial Council, (July 2014) Permission to reproduce this document
More informationREQUIREMENTS FOR CERTIFICATION:
Email: st-medicine@pa.gov INITIAL APPLICATION FOR NURSE-MIDWIFE PRESCRIPTIVE AUTHORITY * A separate prescriptive authority collaborative agreement must be submitted for each physician, physician group
More informationMedicare Advantage and Part D Fraud, Waste and Abuse Compliance Training
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related entities
More informationFederal Regulations For Prescribing Scheduled Controlled Substances
Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system
More informationFraud Waste and Abuse Training Requirement. To Whom It May Concern:
RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)
More informationMEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING
MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING Why Do I Need Training/Where Do I Fit in? Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud,
More informationOregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:
Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain
More informationARTICLE 36: KANE COUNTY DRUG REHABILITATION COURT RULES AND PROCEDURES
ARTICLE 36: KANE COUNTY DRUG REHABILITATION COURT RULES AND PROCEDURES (a) Mission: The Illinois General Assembly has recognized that there is a critical need for a criminal justice program that will reduce
More informationCURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
More informationSTATE OF NEW YORK : : ALLEGANY COUNTY DRUG COUNTY OF ALLEGANY : : TREATMENT COURT. Defendant.
STATE OF NEW YORK : : ALLEGANY COUNTY DRUG COUNTY OF ALLEGANY : : TREATMENT COURT THE PEOPLE OF THE STATE OF NEW YORK against CONTRACT JOHN DOE., Defendant. I, JOHN DOE, agree to enter the Allegany County
More informationUtica College Annual Notice Regarding Drug and Alcohol Abuse Prevention Policies
Utica College Annual Notice Regarding Drug and Alcohol Abuse Prevention Policies Utica College is required by federal law to provide the following notice to all students and employees. This notice is being
More informationMUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS
MUNICIPAL REGULATIONS for CLINICAL NURSE SPECIALISTS CHAPTER 60 CLINICAL NURSE SPECIALIST Secs. 6000 Applicability 6001 General Requirements 6002 Term of Certificate 6003 Renewal of Certificate 6004 Educational
More informationRULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS
RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED NURSE PRACTITIONERS (CRNP) AND CERTIFIED
More informationApplication Fee Explanation
Certified Registered Nurse Anesthetist (CRNA) Information License Required You must hold a current, valid Oregon Certified Registered Nurse Anesthetist license before you practice as a CRNA sign your name,
More informationUnconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35)
Unconsolidated Pennsylvania Statutes HEALTH AND SAFETY (Title 35) Controlled Substance, Drug, Device And Cosmetic Act. 780-113. Prohibited acts; penalties (a) The following acts and the causing thereof
More informationThis section has been included to provide a brief overview of MCP Medical Audit practices, policies, and procedures.
11. AUDIT OF CLAIMS 11.1 OVERVIEW This section has been included to provide a brief overview of MCP Medical Audit practices, policies, and procedures. There are two main audit programs in the Audit Services
More informationGEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)
GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;
More informationDURHAM DWI LAWYER - PIERCE LAW OFFICES - www.piercelaw.com Civil Revocation Statutes - Durham DWI or Drunk Driving
DURHAM DWI LAWYER - PIERCE LAW OFFICES - www.piercelaw.com Civil Revocation Statutes - Durham DWI or Drunk Driving 20-16.5. Immediate civil license revocation for certain persons charged with implied-
More informationRule 6 Adopted at a joint meeting of the District and County Court at Law Judges of Webb County on December 2, 2009
Rule 6 Adopted at a joint meeting of the District and County Court at Law Judges of Webb County on December 2, 2009 Committee Members Pete Garza Hugo Martinez Richard Gonzalez Fernando Sanchez Eduardo
More informationPrime Staffing-Fraud, Waste and Abuse Prevention Training Guide Designed for First-tier, Downstream and Related Entities
Prime Staffing-Fraud, Waste and Abuse Prevention Training Guide Designed for First-tier, Downstream and Related Entities Prime Staffing is providing this Fraud, Waste and Abuse Prevention Training Guide
More informationAPPLICATION TO REGISTER PAIN MANAGEMENT CLINIC
APPLICATION TO REGISTER PAIN MANAGEMENT CLINIC FLORIDA STATUTES Sections 458.3265 and 459.0137, Florida Statutes BOARD RULES Chapter 64B8-9, Florida Administrative Code Chapter 64B15-14, Florida Administrative
More informationNOTICE OF PRIVACY PRACTICES TEMPLATE. Sections highlighted in yellow are optional sections, depending on if applicable
NOTICE OF PRIVACY PRACTICES TEMPLATE Sections highlighted in yellow are optional sections, depending on if applicable Original Date: ##/##/#### Revised per HIPAA Omnibus Rule ##/##/#### Revised Date Implementation:
More informationADDRESSES SYSTEM LOCATION
Volume 80, Number 28 Wednesday, February 11, 2015 Public Notice 9034; Pages 7671 Privacy Act; System of Records: Medical Records, State-24 SUMMARY: Notice is hereby given that the Department of State proposes
More informationFraud, Waste and Abuse Prevention Training
Fraud, Waste and Abuse Prevention Training The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste and abuse training for organizations providing health services to MA or Medicare
More informationDo You Know Where the Drugs Are Going? Partners in Integrity
Do You Know Where the Drugs Are Going? Partners in Integrity Objectives At the conclusion of this presentation, participants will be able to: Identify common types of drug diversion activities. List at
More information